Skip to main content

Day: May 6, 2022

Taaleri Plc Interim Statement 1 January–31 March 2022: Taaleri’s continuing earnings increased to EUR 9.3 million in Q1, but unrealized changes in the fair value of investment operations weighed on income and operating profit

TAALERI PLC                STOCK EXCHANGE RELEASE        6 MAY 2022 AT 8:00 (EEST) Taaleri Plc Interim Statement 1 January–31 March 2022: Taaleri’s continuing earnings increased to EUR 9.3 million in Q1, but unrealized changes in the fair value of investment operations weighed on income and operating profit January–March 2022Continuing earnings grew by 4.3% to EUR 9.3 (8.9) million. The continuing earnings of the Private Asset Management segment grew by 15.8% to EUR 4.9 (4.2) million, and the continuing earnings of the Strategic Investments segment by 7.5% to EUR 3.9 (3.6) million. Performance fees were EUR 0.5 (0.8) million and earnings from investment operations were EUR -2.6 (4.0) million due to changes in fair value. Income was EUR 7.2 (13.7) million, a decrease of 47.6% due to unrealized changes in the fair value of investment...

Continue reading

Scatec ASA: First quarter impacted by Ukraine

Oslo, 6 May 2022: In the first quarter 2022, Scatec’s proportionate revenues reached NOK 1,014 million (954) with an EBITDA of NOK 398 million (636). Power production reached 868 GWh (854).  “Our first-quarter results were impacted by Russia’s war in Ukraine, the broader geopolitical uncertainty and seasonality in the Philippines. Moving forward, we expect to bring our backlog into construction during this year and we will continue to grow our pipeline in core markets for our traditional renewable energy solutions. In addition, we will have a strong focus on further developing our green ammonia and green hydrogen business,” says Terje Pilskog, CEO of Scatec. “We will execute our growth strategy by applying focus and discipline in everything we do, and I look forward to continuing developing our strong position as a leader in renewable...

Continue reading

First quarter 2022 results: SCOR absorbs the combined impact of potential claims related to the conflict in Ukraine, a series of natural catastrophes and the continuation of the pandemic in the United States

First quarter 2022 results SCOR absorbs the combined impact of potential claims related to the conflict in Ukraine, a series of natural catastrophes and the continuation of the pandemic in the United StatesGross written premiums of EUR 4,715 million in Q1 2022, up 9.7%1 compared with Q1 2021 Net loss of EUR 80 million in Q1 2022, compared with EUR 45 million net income in Q1 2021 Shareholders’ equity of EUR 6,064 million at the end of March 2022, implying a book value per share of EUR 33.89, down -3.9 % from December 31, 2021 (EUR 35.26) Estimated solvency ratio of 240% at the end of March 2022 (up from 226% at the end of 2021) Completion of the announced EUR 200 million share buy-backSCOR SE’s Board of Directors met on May 5, 2022, under the chairmanship of Denis Kessler, to approve the Group’s Q1 2022 financial statements. Key...

Continue reading

ING posts 1Q2022 net result of €429 million and strong pre-provision profit

  ING posts 1Q2022 net result of €429 million and strong pre-provision profit  1Q2022 profit before tax of €668 million; CET1 ratio remains robust at 14.9%• Income strong with robust net interest income and continued increase in fee income• Operating expenses under control, lower than a year ago and sequentially• Retail Banking result 20% higher than in 1Q2021 on lower expenses and risk costs, despite impairment on TTB• Wholesale Banking results impacted by €834 million risk costs linked to Russia-related exposure• Additional capital distribution of €1.25 billion  CEO statement“The first quarter of 2022 was marked by the terrible invasion of Ukraine, which is having a devastating impact on people’s lives and is threatening international stability and security,” said ING CEO Steven van Rijswijk....

Continue reading

Hywin Holdings to present at the dbVIC – Deutsche Bank ADR Virtual Investor Conference on May 11, 2022

Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event SHANGHAI, China, May 06, 2022 (GLOBE NEWSWIRE) — Hywin Holdings Ltd. (“Hywin Wealth”, “Hywin”, or the “Company”) (NASDAQ: HYW) a leading independent wealth management service provider in China, today announced that Mr. Lawrence Lok, Chief Financial Officer, and  Mr. Ryan Teng, Director of Investor Relations, will present at the dbVIC – Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on May 11. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors.DATE: May 11, 2022TIME: 08:30 a.m. ETLINK: https://bit.ly/3KOZShVThis will be a live, interactive online event where investors...

Continue reading

PepGen Announces Pricing of Initial Public Offering

BOSTON, May 05, 2022 (GLOBE NEWSWIRE) — PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the pricing of its initial public offering. The offering consists of 9,000,000 shares of common stock at an initial public offering price of $12.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by PepGen, are expected to be $108.0 million. In addition, PepGen has granted the underwriters a 30-day option to purchase up to an additional 1,350,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. All of the shares of common stock...

Continue reading

ECN Capital Schedules Q1-2022 Conference Call

TORONTO, May 05, 2022 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or “the Company”) announced today that it intends to file its financial statements and management discussion and analysis for the three-month period ended March 31, 2022 after markets close on Thursday, May 12, 2022. The Company will host an analyst briefing to discuss these results commencing at 5:30 PM (ET) on Thursday, May 12, 2022. The call can be accessed as follows:  Webcast https://services.choruscall.ca/links/ecncapitalcorp20220512.html       Toll-free dial in North America 1-800-319-8560International 1-604-638-5345  Presentation slides http://ecncapitalcorp.com/investors/presentationsA telephone replay of the conference call may also be accessed until June 12, 2022 by dialing 1-800-319-6413 and entering the passcode 8596#. About...

Continue reading

NIO Inc. Announces Proposed Secondary Listing on the Singapore Exchange

SHANGHAI, China, May 05, 2022 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced the proposed secondary listing of its Class A ordinary shares, par value US$0.00025 per share (the “Shares”), by way of introduction on the Main Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). The Company’s American depositary shares (the “ADSs”), each representing one Share, will continue to be primarily listed and traded on the New York Stock Exchange (the “NYSE”). The Company has received a conditional eligibility-to-list letter (“ETL”) from the SGX-ST on May 5, 2022 for the listing and quotation of the Shares on the Main Board of the SGX-ST. The ETL is not an indication of the merits of the proposed...

Continue reading

Immuron appoints Mr. Steven Lydeamore as Chief Executive Officer

MELBOURNE, Australia, May 05, 2022 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, is pleased to announce the appointment of Steven Lydeamore as Chief Executive Officer (CEO) of the Company effective 27 June 2022. Mr. Lydeamore has 30 years international pharmaceutical experience, working in Australia, Canada and USA. Mr. Lydeamore brings valuable international experience having spent eleven years working at Canadian global pharmaceutical company Apotex Inc., and four years for Mayne Pharma (USA) Limited. This includes valuable experience in mergers and acquisitions, finance, business development, sales and marketing, manufacturing, and research and development....

Continue reading

Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual Meeting

SP-102 (SEMDEXATM) is the first non-opioid novel injectable corticosteroid gel formulation product in development for the treatment of lumbar radicular pain, and it contains no preservatives, surfactants, solvents, or particulates. The study met its primary endpoint with a highly statistically significant reduction in average daily leg pain in patients receiving SEMDEXATM compared to placebo (p

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.